Jiangxi Sanxin Medtec Co.,Ltd.

SZSE:300453 Stock Report

Market Cap: CN¥4.0b

Jiangxi Sanxin MedtecLtd Management

Management criteria checks 4/4

Jiangxi Sanxin MedtecLtd's CEO is Zhiping Mao, appointed in Mar 2020, has a tenure of 5.17 years. directly owns 0.58% of the company’s shares, worth CN¥23.25M. The average tenure of the management team and the board of directors is 5.2 years and 5.4 years respectively.

Key information

Zhiping Mao

Chief executive officer

CN¥713.8k

Total compensation

CEO salary percentagen/a
CEO tenure5.2yrs
CEO ownership0.6%
Management average tenure5.2yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

Investors Shouldn't Be Too Comfortable With Jiangxi Sanxin MedtecLtd's (SZSE:300453) Earnings

Oct 21
Investors Shouldn't Be Too Comfortable With Jiangxi Sanxin MedtecLtd's (SZSE:300453) Earnings

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 37%

Oct 08
Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 37%

Returns Are Gaining Momentum At Jiangxi Sanxin MedtecLtd (SZSE:300453)

Sep 30
Returns Are Gaining Momentum At Jiangxi Sanxin MedtecLtd (SZSE:300453)

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Apr 23
Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Apr 04
Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Mar 29
Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

CEO

Zhiping Mao (50 yo)

5.2yrs
Tenure
CN¥713,800
Compensation

Mr. Zhiping Mao serves as Director of Jiangxi Sanxin Medtec Co.,Ltd. since December 26, 2010 and serves as its General Manager since March 26, 2020 and served as its Deputy General Manager.


Leadership Team

NamePositionTenureCompensationOwnership
Zhiping Mao
GM & Non-Independent Director5.2yrsCN¥713.80k0.58%
CN¥ 23.3m
Ming Liu
VP, Acting Financial Director5.4yrsCN¥679.90k0.13%
CN¥ 5.2m
Ling Peng
Vice President9.4yrsCN¥679.90k0.091%
CN¥ 3.7m
Ganying Wang
Vice President4.2yrsCN¥679.90k0.18%
CN¥ 7.1m
Lingli Leng
Vice President3.2yrsCN¥664.90k0.10%
CN¥ 4.1m
Nan Mei Shu
Accounting Officerno datano datano data
5.2yrs
Average Tenure
42yo
Average Age

Experienced Management: 300453's management team is seasoned and experienced (5.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zhiping Mao
GM & Non-Independent Director14.4yrsCN¥713.80k0.58%
CN¥ 23.3m
Ming Liu
VP, Acting Financial Director4.1yrsCN¥679.90k0.13%
CN¥ 5.2m
Fenglian Lei
Vice Chairman14.4yrsCN¥713.80k5.27%
CN¥ 212.1m
Zhenrong Le
Non-Independent Director2.1yrsCN¥679.90k0.31%
CN¥ 12.3m
Guofeng Chen
Independent Director2.1yrsCN¥45.50kno data
Yixing Peng
Non-Independent Chairman14.4yrsCN¥793.10k25.07%
CN¥ 1.0b
Zhenzhu Yu
Chairman of the Board of Supervisors9.4yrsno datano data
Haihong Jiang
Independent Director5.4yrsCN¥78.00kno data
Lin Zhang
Non-Employee Supervisor8.4yrsno data0.062%
CN¥ 2.5m
Meihua Zeng
Supervisor4.8yrsno datano data
Xiaohua Xia
Independent Director2.1yrsCN¥45.50kno data
5.4yrs
Average Tenure
49yo
Average Age

Experienced Board: 300453's board of directors are considered experienced (5.4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 19:46
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jiangxi Sanxin Medtec Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin Ju SunGuotai Junan Securities